glycoconjugate vaccine (Ancora Pharmaceuticals)

N/A

Report date: 2026/01/23 11:09:42

Base Information

Drug Nameglycoconjugate vaccine (Ancora Pharmaceuticals)

Drug Alias Namesynthetic carbohydrate-based vaccine (Ancora Pharmaceuticals)

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsAnemiaMalaria

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAncora Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAncora Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsAnemiaMalaria

Other Information

ATC CodeN/A